Preliminary Investigation of the Advertising and Availability of PREPs, the New “Safe” Tobacco Products

By Hickman Norval   Klonoff Elizabeth A.   Landrine Hope   Kashima Kennon   Parekh Bina   Fernandez Senaida   Thomas KaMala   Brouillard Catherine   Zolezzi Michele   Jensen Jennifer   Weslowski Zorahna  

Journal of Behavioral Medicine, Vol. 27, Iss. 4, 2004-08 ,pp. : 413-424

Springer Publishing Company

Access to resources Recommend Favorite

Existing and new criteria for bioequivalence evaluation of new controlled release (CR) products of carbamazepine

By Bialer M.   Arcavi L.   Sussan S.   Volosov A.   Yacobi A.   Moros D.   Levitt B.   Laor A.  

Epilepsy Research, Vol. 32, Iss. 3, 1998-11 ,pp. : 371-378

Elsevier

Access to resources Recommend Favorite

In Vivo Assessment of Lipid Peroxidation Products Associated with Age-Related Neurodegenerative Diseases

By Ou J.J.   Zhang Y.   Montine T.J.  

Experimental Neurology, Vol. 175, Iss. 2, 2002-06 ,pp. : 363-369

Elsevier

Access to resources Recommend Favorite

Localizations of endogenous APP/APP-Proteolytic products are consistent with microtubular transport

By Zitnik Galynn   Wang Lin   Martin George   Hu Qubai  

Journal of Molecular Neuroscience, Vol. 31, Iss. 1, 2007-02 ,pp. : 59-68

Humana Press, Inc

Access to resources Recommend Favorite

Ischemic stroke after using over the counter products containing ephedra

By Chen C.   Biller J.   Willing S.J.   Lopez A.M.  

Journal of the Neurological Sciences, Vol. 217, Iss. 1, 2004-01 ,pp. : 55-60

Elsevier

Access to resources Recommend Favorite